Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
Crossref DOI link: https://doi.org/10.1007/s10549-017-4587-8
Published Online: 2017-11-27
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Press, David J. http://orcid.org/0000-0003-3898-3156
Ibraheem, Abiola
Dolan, M. Eileen
Goss, Kathleen H.
Conzen, Suzanne
Huo, Dezheng
Funding for this research was provided by:
Susan G. Komen (GTDR16376189)
License valid from 2017-11-27